The upregulated expression of SGLT in these conditions led to intracellular sodium accumulation and downstream myocardial dysfunction

Introduction Chronic kidney disease (CKD) is characterized by chronic structural damage and dysfunction of the kidneys caused by a variety of etiological factors, with a duration of more than 3 months ( Although the pathogenesis of CKD is complex and diverse and multiple pathological processes interact during disease progression, the prevailing view suggests that the accumulation of gut-derived uremic toxins (GUTs) in vivo may be a central factor in the occurrence and progression of CKD ( Given the impact of GUTs on CKD, in recent years, researchers have attempted to reduce the production of GUTs by killing GUT-producing bacteria, reducing substrate uptake, and inhibiting the function of related enzymes to slow the progression of CKD ( Astaxanthin (AST) is a small-molecule fat-soluble pigment belonging to the carotenoid family, which is widely found in shrimp, crabs, salmon, oysters, algae and fungi ( To address the unresolved mechanisms of AST in CKD, this study combined network pharmacology prediction with experimental validation

According to a randomized controlled trial, tapentadol (100250 mg) was effective and well tolerated for the management of moderate-to-severe chronic pain associated with DPN [131]
Peptide therapy should be individualized and integrated into a comprehensive strategy that includes nutrition, exercise, sleep optimization, stress management, and metabolic health assessment